bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.03.27.645705

Evidence for a RIPK1-independent survival mechanism for CASPASE-8 in αβ T cells

Abstract

CASPASE8 promotes both cell death and survival by acting as a trigger of apoptosis but also a repressor of necroptosis. In T cells, CASPASE8 is required for FAS induced apoptosis, but protects activated T cells from necroptosis. The broader role and mechanisms of CASPASE8 in the wider T cell compartment is less certain. Here, we analysed mice in which Casp8 was conditionally deleted in the lymphoid compartment by huCD2iCre. In the thymus, we found evidence of a modest impairment of early thymic progenitors and a striking absence of NKT cell development. Amongst mature peripheral T cells, there was a substantial and specific reduction in the CD8 T cell compartment, that included naive, central memory and virtual memory subsets. While life spans and turnover of CD8 T cells appeared largely normal, we did identify an acute requirement for continued CASPASE8 expression for survival of a fraction of CD8 T cells, since induced Casp8 deletion by tamoxifen induced CD8CreERT resulted in an acute loss of CD8 T cells. CASPASE8 deficient T cells were resistant to FAS or TNF induced cell death in vitro. Generating Casp8 deficient mice that express a kinase dead RIPK1 confirmed that necroptosis contributed to death of thymic progenitors and some peripheral CD8 T cell subsets in the absence of CASPASE8. However, kinase dead RIPK1 failed to restore NKT cell development and only partially rescued CD8 VM T cells, while analysing mixed bone marrow chimeras suggested that CASPASE8 deficient CD4 and CD8 T cells were less competitively fit than WT T cells, even in the absence of RIPK1 kinase activity. These latter observations suggest the existence of a novel mechanism by which CASPASE8 promotes T cell survival that is independent of its established role in repressing necroptosis.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Islam, F., Layzell, S., Boal-Carvalho, I., Seddon, B.. 2025-04-01. Evidence for a RIPK1-independent survival mechanism for CASPASE-8 in αβ T cells. https://doi.org/10.1101/2025.03.27.645705

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Common viral infections seed regionally distinct resident memory T cells in the human CNS

T cells persist in the central nervous system (CNS) and can drive both protection and neurological disease. How these cells are organized in humans and what they recognize is largely unknown. Here, we profiled CD8 T cells across anatomically distinct CNS regions, obtained through on-site autopsies and temporal lobe resection surgeries, using single-cell RNA sequencing, paired T cell receptor sequencing, and DNA-barcoded tetramers. Resident memory T cells (TRM) specific for Epstein-Barr virus, cytomegalovirus, influenza A, and SARS-CoV-2 were identified across CNS compartments. Anatomical location was the strongest correlate of TRM cell state, with leptomeningeal cells adopting a cytokine-poised TRM program, whereas brain TRM cells were transcriptionally restrained. Cells of the same clonotype spanned tissues yet adopted local transcriptional states. Viral specificity added another layer of TRM heterogeneity with GZMK/GZMA-expressing EBV-specific populations and interferon-stimulated gene signatures in SARS-CoV-2 and Influenza A-specific cells. The human CNS thus harbors regionally distinct CD8+ TRM shaped by common viral exposures.

immunology↗

A regulatory T cell signature provides a shared molecular basis for the therapeutic window of opportunity in rheumatic disease

Rheumatic diseases, including rheumatoid arthritis (RA), spondyloarthritis (SpA) and osteoarthritis (OA), show distinct phenotypes yet respond to overlapping therapies, implicating shared immune mechanisms. In the Transimmunom cohort, we profiled peripheral blood from 240 individuals (47 healthy, 44 OA, 91 RA, 58 SpA) across deep immunophenotyping, immunoproteomics and Treg-Teff transcriptomics. Single-layer analyses revealed broader Treg than Teff remodeling, along with a shared pattern of reduced activated Tregs and expanded Helios+ Tregs across all diseases, alongside a decrease in functional Treg subpopulations, including CTLA4+ and CD45RA- Tregs. In RA specifically, LAG3+ Tregs were also expanded. Combining omics layers outperformed single-layer approaches for disease classification. Among individual layers, Treg transcriptomes were most discriminative, and integration uncovered disease-specific programs. Unsupervised clustering identified a cross-disease cluster independent of activity, treatment and age, mapping to early disease (<= years) and dominated by a Treg dysfunction-associated program. These results provide a biological rationale for the therapeutic "window of opportunity" concept and duration-stratified Treg-directed trials.

immunology↗

Inhibitory Fc Receptor sets a time limit on macrophage response to IgG

Antibodies engage both activating Fc Receptors and the inhibitory receptor Fc{gamma}RIIB. Why macrophages need a dedicated inhibitory receptor rather than simply tuning activating receptor signaling is unclear. Using DNA-based chimeric receptors and in silico modeling, we independently controlled activating and inhibitory Fc Receptors. We found that Fc{gamma}RIIB imposed a time limit on macrophage phagocytosis and ERK signaling. The time limit is due to activating Fc Receptors converting PI(4,5)P2 to PI(3,4,5)P3, which is subsequently converted to PI(3,4)P2 by Fc{gamma}RIIB. This leads to a pulse of active signaling, which is sufficient for phagocytosis of small bacteria-sized targets but not phagocytosis of large targets and TNF secretion. Unlike engaging Fc{gamma}RIIB, reducing activating Fc Receptor signaling decreased initiation of phagocytosis, the speed of PI(3,4,5)P3 generation, and the amplitude of ERK signaling. Our results demonstrate that Fc{gamma}RIIB controls the duration of IgG signaling, while the activating Fc Receptors control sensitivity.

immunology↗